Extensive interstitial lung disease in inflammatory myopathy is a strong predictor of mortality

D. Assayag (Montréal, QC, Canada)

Source: International Congress 2017 – The spectrum of CTDs: from pathogenesis to treatment
Session: The spectrum of CTDs: from pathogenesis to treatment
Session type: Thematic Poster
Number: 890
Disease area: Interstitial lung diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
D. Assayag (Montréal, QC, Canada). Extensive interstitial lung disease in inflammatory myopathy is a strong predictor of mortality. 890

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Predictors of mortality and risk prediction among patients with scleroderma related interstitial lung disease
Source: International Congress 2015 – IPF: clinical aspects II
Year: 2015



Using the ILD-GAP model to predict mortality in chronic interstitial lung disease
Source: International Congress 2015 – IIPs: orphan
Year: 2015


Addition of respiratory hospitalizations 24weeks prior to the ILD-GAP model to predict mortality in chronic interstitial lung disease
Source: International Congress 2016 – Clinical aspects of ILD
Year: 2016


Frequency and impact of interstitial lung disease on clinical state and mortality in systemic scleroderma
Source: Annual Congress 2012 - Diffuse parenchymal lung disease III
Year: 2012

The epidemiology of idiopathic pulmonary fibrosis and interstitial lung diseases at risk of a progressive-fibrosing phenotype
Source: Eur Respir Rev, 27 (150) 180077; 10.1183/16000617.0077-2018
Year: 2018



Variation in mortality from interstitial lung disease by diagnosis
Source: International Congress 2015 – IIPs: orphan
Year: 2015


Radiologic pattern as a survival predictor in the rheumatoid artritis intersticial lung disease
Source: International Congress 2015 – Connective tissue disorders
Year: 2015

A multicentre evaluation of inter-multidisciplinary team agreement for predicted disease behaviour and management strategy in diffuse lung disease
Source: International Congress 2016 – Epidemiological and clinical data regarding the modern management of chronic lung diseases
Year: 2016

Prognostic factors of interstitial lung disease associated with primary Sjögren's syndrome
Source: Annual Congress 2013 –Diffuse parenchymal lung disease I
Year: 2013


Study of factors affecting mortality in ILD cases over 2 years
Source: International Congress 2016 – Clinical aspects of ILD
Year: 2016


A multicentre evaluation of inter-multidisciplinary team agreement for diagnosis in diffuse lung disease
Source: International Congress 2016 – Epidemiological and clinical data regarding the modern management of chronic lung diseases
Year: 2016

Bacterial burden in the lower airways predicts disease progression in idiopathic pulmonary fibrosis and is independent of radiological disease extent
Source: Eur Respir J, 55 (4) 1901519; 10.1183/13993003.01519-2019
Year: 2020



Predictors of progression in systemic sclerosis patients with interstitial lung disease
Source: Eur Respir J, 55 (5) 1902026; 10.1183/13993003.02026-2019
Year: 2020



The analysis of prognostic factors in patients with interstitial lung diseases
Source: International Congress 2015 – New insights into IIPs
Year: 2015


Co-morbidities and cause of death in patients with rheumatoid arthritis associated interstitial lung disease
Source: International Congress 2015 – Connective tissue disorders
Year: 2015

Potential causes of acute deterioration in patients with interstitial lung disease
Source: Annual Congress 2010 - Different patterns of interstitial lung disease
Year: 2010

Rituximab in severe, progressive interstitial lung disease
Source: International Congress 2016 – Connective tissue disorders
Year: 2016

Nintedanib reduces fibrotic markers in the lung in a model of rheumatoid arthritis associated interstitial lung disease
Source: International Congress 2016 – ILD pathogenesis
Year: 2016

Overall survival is significantly higher in sarcoidosis than in IPF patients after lung transplantation
Source: Annual Congress 2013 –Clinical studies in lung transplantation
Year: 2013


Are risk predicting models useful for estimating survival in rheumatoid arthritis-associated interstitial lung disease?
Source: International Congress 2016 – Connective tissue disorders
Year: 2016